These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 19500509)
21. [Expression of cyclooxygenase-2 and urokinase plasminogen activator in gastric carcinoma and the clinical significance thereof]. Zhang FH; Zhou YN; Li GZ; Li Q; Lu B; Zhang ZY; Wu ZQ; Fan P; Hao TJ Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3279-82. PubMed ID: 19159555 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613 [TBL] [Abstract][Full Text] [Related]
24. [Expression and significance of cell cycle regulators in gastric carcinoma]. Wu JF; Shao JC; Wang DB; Qin R; Zhang H Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028 [TBL] [Abstract][Full Text] [Related]
25. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Yonemura Y; Endo Y; Fujita H; Fushida S; Ninomiya I; Bandou E; Taniguchi K; Miwa K; Ohoyama S; Sugiyama K; Sasaki T Clin Cancer Res; 1999 Jul; 5(7):1823-9. PubMed ID: 10430087 [TBL] [Abstract][Full Text] [Related]
26. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters. Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma. Raica M; Mogoantă L; Cîmpean AM; Alexa A; Ioanovici S; Mărgăritescu C; Lazăr D; Izvernariu D Rom J Morphol Embryol; 2008; 49(1):37-42. PubMed ID: 18273500 [TBL] [Abstract][Full Text] [Related]
28. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma]. Sha D; He YJ Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593 [TBL] [Abstract][Full Text] [Related]
29. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression. Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384 [TBL] [Abstract][Full Text] [Related]
30. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
31. Value of expression of insulin-like growth factor-1 receptor in gastric adenocarcinomas and normal gastric tissues. Topalak Ö; Uğur Kantar F; Ulukuş Ç; Küpelioğlu A Turk J Gastroenterol; 2014 Apr; 25(2):141-6. PubMed ID: 25003672 [TBL] [Abstract][Full Text] [Related]
32. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140 [TBL] [Abstract][Full Text] [Related]
33. [Study of gastric carcinoma and PCNA and c-met gene abnormality]. Ji J; Zhao P; Huang B Wei Sheng Yan Jiu; 2008 Jul; 37(4):479-82. PubMed ID: 18839537 [TBL] [Abstract][Full Text] [Related]
34. [Infection with L-form of Helicobacter pylori and expressions of MIF, MMP9 and VEGF in gastric carcinoma]. Ou Y; Kang M; Zhou L; Cheng Z; Tang S; Yu D Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):180-7. PubMed ID: 24589592 [TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor-1 receptor (IGF-1R) in primary and metastatic undifferentiated carcinoma of the head and neck: a possible target of immunotherapy. Friedrich RE; Hagel C; Bartel-Friedrich S Anticancer Res; 2010 May; 30(5):1641-3. PubMed ID: 20592355 [TBL] [Abstract][Full Text] [Related]
36. [The relationship of MMP-9, VEGF and PCNA expressions and their clinical significance in gastric adenocarcinoma]. Zhao FJ; Kang CS; Cui XW; Song XM; Liu J; Zhang QY Zhonghua Nei Ke Za Zhi; 2009 Feb; 48(2):114-7. PubMed ID: 19549464 [TBL] [Abstract][Full Text] [Related]
37. Expression levels of insulin-like growth factor-1 and multidrug resistance-associated protein-1 indicate poor prognosis in patients with gastric cancer. Ge J; Chen Z; Wu S; Chen J; Li X; Li J; Yin J; Chen Z Digestion; 2009; 80(3):148-58. PubMed ID: 19713703 [TBL] [Abstract][Full Text] [Related]
38. [Expression of PTEN-encoding product in different stages of carcinogenesis and progression of gastric carcinoma]. Zheng HC; Chen Y; Kuang LG; Yang L; Li JY; Wu DY; Zhang SM; Xin Y Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):13-6. PubMed ID: 12678979 [TBL] [Abstract][Full Text] [Related]
39. [Impact of HER2, EGFR, IGF-1R, and VEGFR expressions on the outcome of chemotherapy for advanced gastric cancer]. Matsubara J; Hirashima Y; Yamada Y Gan To Kagaku Ryoho; 2010 Aug; 37(8):1489-96. PubMed ID: 20716873 [TBL] [Abstract][Full Text] [Related]
40. Expression of some tumor associated factors in human carcinogenesis and development of gastric carcinoma. Zhao MD; Hu XM; Sun DJ; Zhang Q; Zhang YH; Meng W World J Gastroenterol; 2005 Jun; 11(21):3217-21. PubMed ID: 15929170 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]